share_log

Bellerophon Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Janus Henderson Group plc(12.1%),Janus Henderson Biotech Innovation Master Fund Ltd(10.4%)

SEC announcement ·  May 26, 2023 16:41
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more